Exercise therapy trial for people with familial adenomatous polyposis
Part of Cancer, Digestive system, Genetic & congenital clinical trials.
This trial tests whether a home-based exercise program can help people with familial adenomatous polyposis (FAP) who have rectal polyps. You may qualify if you have FAP, have not had your rectum removed, have at least 5 rectal polyps larger than 2 mm, and are currently inactive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with FAP (either through genetic testing or because you have had more than 50 colorectal polyps).
- You still have your rectum (either you have not had colon surgery or you have had a partial colectomy that left your rectum in place).
- You have at least 5 rectal polyps that are larger than 2 mm on a recent colonoscopy.
- You have had no active cancer in the last 6 months and are at least 6 months past any cancer treatment.
- You have not started taking certain anti-inflammatory drugs (like sulindac or celecoxib) or weight loss medications (like semaglutide) in the last 3 months.
- You are currently inactive (less than 60 minutes of moderate or hard exercise per week) and have space for a treadmill at home.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called ONC201 to see if it can safely help prevent colon polyps from coming back in people at high risk. You will take the drug for about 12 weeks and have a second colonoscopy to check results.
This early-phase trial studies REC-4881 in adults with familial adenomatous polyposis (FAP), a condition that causes many colon/rectum and duodenal polyps. It aims to see whether the treatment can safely help control or shrink polyp growth in people who have had bowel surgery.
This trial tests a new drug, TPST-1495, to reduce the number of benign polyps in the small intestine for people with a condition called familial adenomatous polyposis (FAP). If you join, you will likely not know if you receive the drug or a placebo, to see if the drug is helpful.
This study tracks how colorectal polyps develop in people with familial adenomatous polyposis (FAP), a genetic condition that causes many polyps. It aims to better understand and possibly prevent cancer, without immediate surgery.
This trial studies a tailored plan for surveillance (check-ups) and interventions to find and remove new growths early in people with familial adenomatous polyposis (FAP) after bowel surgery. It may help lower the chance of cancer by closely monitoring and treating polyps when they appear.
This trial tests a personalized plan for regularly checking and treating stomach and first-part of intestine polyps in people with familial adenomatous polyposis (FAP). It may help by catching problems early and choosing the right intervention at the right time.
Hear when a new Familial Adenomatous Polyposis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.